The Use of Oral HIV Pre-exposure Prophylaxis Among People Who Inject Drugs: Barriers, and Recommendations

Overview

Journal Front Public Health

Specialty Public Health

Date 2023 Sep 21

PMID 37732092

Authors

Tafadzwa Dzinamarira

Enos Moyo

Affiliations

Soon will be listed here.

Citing Articles

Access to and acceptability of sexual and reproductive health, harm reduction and other essential health services among people who inject drugs in Durban, South Africa.

Milford C, Cavanagh T, Bosman S, Wilson M, Smit J, Zanoni B Harm Reduct J. 2024; 21(1):123.

PMID: 38926755 PMC: 11200820. DOI: 10.1186/s12954-024-01042-6.

Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment.

Bradford W, Akselrod H, Bassler J, Gagnon K, Burkholder G, Carpenter J Addict Sci Clin Pract. 2024; 19(1):22.

PMID: 38528590 PMC: 10964564. DOI: 10.1186/s13722-024-00451-z.

References

Mburu G, Limmer M, Holland P . HIV risk behaviours among women who inject drugs in coastal Kenya: findings from secondary analysis of qualitative data. Harm Reduct J. 2019; 16(1):10. PMC: 6364406. DOI: 10.1186/s12954-019-0281-y. View

Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Mock P, Leethochawalit M . The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 2015; 29(7):819-24. DOI: 10.1097/QAD.0000000000000613. View

Paquette C, Syvertsen J, Pollini R . Stigma at every turn: Health services experiences among people who inject drugs. Int J Drug Policy. 2018; 57:104-110. PMC: 5994194. DOI: 10.1016/j.drugpo.2018.04.004. View

Biello K, Bazzi A, Mimiaga M, Biancarelli D, Edeza A, Salhaney P . Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018; 15(1):55. PMC: 6233595. DOI: 10.1186/s12954-018-0263-5. View

Dengo-Baloi L, Boothe M, Sema Baltazar C, Sathane I, Langa D, Condula M . Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment. BMC Public Health. 2020; 20(1):975. PMC: 7310000. DOI: 10.1186/s12889-020-09068-8. View

Muncan B, Walters S, Ezell J, Ompad D . "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 2020; 17(1):53. PMC: 7393740. DOI: 10.1186/s12954-020-00399-8. View

Iseselo M, Tarimo E, Sandstrom E, Kulane A . Awareness and willingness to use HIV oral pre-exposure prophylaxis among people who inject drugs in Dar es Salaam, Tanzania: A cross-sectional survey. PLOS Glob Public Health. 2023; 2(11):e0000776. PMC: 10121179. DOI: 10.1371/journal.pgph.0000776. View

Rosen J, Zhang L, Pelaez D, Park J, Glick J . A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation. AIDS Behav. 2023; 27(7):2440-2453. PMC: 9810241. DOI: 10.1007/s10461-022-03971-4. View

Likindikoki S, Meyrowitsch D, Mizinduko M, Ishungisa A, Tersbol B, Leyna G . Socio-cognitive factors influencing access to HIV prevention services among people who inject drugs in Dar es Salaam, Tanzania: An integrated bio-behavioural survey. PLoS One. 2022; 17(1):e0261500. PMC: 8797198. DOI: 10.1371/journal.pone.0261500. View

10.

Hogan S, Page A, Ogbo F, Dixit S, Rajbhandari R, Rawal B . Trends and determinants of HIV transmission among men who inject drugs in the Pokhara Valley, Nepal: analysis of cross-sectional studies. BMC Public Health. 2021; 21(1):269. PMC: 7856790. DOI: 10.1186/s12889-021-10331-9. View

11.

Sherman S, Schneider K, Park J, Allen S, Hunt D, Chaulk C . PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug Alcohol Depend. 2019; 195:148-155. PMC: 6436943. DOI: 10.1016/j.drugalcdep.2018.08.014. View

12.

Fernandes R, Cary M, Duarte G, Jesus G, Alarcao J, Torre C . Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews. BMC Public Health. 2017; 17(1):309. PMC: 5387338. DOI: 10.1186/s12889-017-4210-2. View

13.

Walters S, Kral A, Simpson K, Wenger L, Bluthenthal R . HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018. Subst Use Misuse. 2020; 55(14):2409-2419. PMC: 7665852. DOI: 10.1080/10826084.2020.1823419. View

14.

Belludi A, McFall A, Solomon S, Celentano D, Mehta S, Srikrishnan A . Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey. PLoS One. 2021; 16(2):e0247352. PMC: 7906475. DOI: 10.1371/journal.pone.0247352. View

15.

Strathdee S, Kuo I, El-Bassel N, Hodder S, Smith L, Springer S . Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose. AIDS. 2020; 34(14):1997-2005. PMC: 7606503. DOI: 10.1097/QAD.0000000000002673. View

16.

Streed Jr C, Morgan J, Gai M, Larochelle M, Paasche-Orlow M, Taylor J . Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use. JAMA Netw Open. 2022; 5(7):e2221346. PMC: 9277489. DOI: 10.1001/jamanetworkopen.2022.21346. View

17.

Shaw G, Schaefer R, Schmidt H, Madden A, Chang J, Mozalevskis A . Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery. Harm Reduct J. 2023; 20(1):16. PMC: 9924874. DOI: 10.1186/s12954-023-00729-6. View

18.

Henderson M, Schmidt H, Chitembo L, Peralta H, Alaama A, Johnson C . The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Global Qualitative Consultation on Provider Perspectives on New Products and Differentiated Service Delivery. AIDS Behav. 2023; 27(11):3755-3766. PMC: 10589125. DOI: 10.1007/s10461-023-04093-1. View

19.

Allen S, ORourke A, White R, Smith K, Weir B, Lucas G . Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study. AIDS Behav. 2019; 24(6):1942-1950. PMC: 7228835. DOI: 10.1007/s10461-019-02767-3. View

20.

Dutta M . Disseminating HIV pre-exposure prophylaxis information in underserved communities. Am J Prev Med. 2012; 44(1 Suppl 2):S133-6. DOI: 10.1016/j.amepre.2012.09.030. View